Concord Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 09, 2025
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has called its 40th AGM on September 9, 2025 at 4:00 PM via video conferencing. Shareholders will consider adopting audited financial statements for FY25 and approving a dividend of Rs. 10.70 per equity share (face value Rs. 1). Mr. Rajiv Agarwal is being re-appointed as a director (retiring by rotation). The notice also seeks shareholder approval to ratify the remuneration of Cost Auditors (M/s. Dalwadi & Associates) at Rs. 3.70 lakh plus GST, appoint M/s. Ashish Shah & Associates as Secretarial Auditors for 5 years (FY26 to FY30) at Rs. 1.25 lakh per year, and approve loans/guarantees up to Rs. 115 crore under Section 185 of the Companies Act. Record date for the dividend is September 3, 2025, and e-voting runs from September 6 to September 8, 2025.
Shareholders on the books as of September 3, 2025 will be eligible for the Rs. 10.70 per share dividend. The Rs. 115 crore related-party loan approval is a routine enabling resolution but worth noting for its size relative to the company. No immediate material change to the stock price is expected from procedural AGM items.